missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Bioactive Small Molecules
  5. STEMCELL Technologies (±)-Flurbiprofen

STEMCELL Technologies (±)-Flurbiprofen

Product Code. 17160292
Encompass_Preferred
Click to view available options
Quantity:
1 g
5 g
Unit Size:
1g
5g
This item is not returnable. View return policy

Product Code. 17160292

Brand: STEMCELL Technologies 73924

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

PI3K/AKT pathway inhibitor; Inhibits COX-1 and COX-2

  • (±)-Flurbiprofen is a cell-permeable and non-steroidal anti-inflammatory agent
  • It is a potent non-selective inhibitor of cyclooxygenase (COX) with EC50 = 0.1 and 0.4 μM for the inhibition of recombinant human COX-1 and COX-2, respectively (Gierse et al.)
  • Maintains self-renewal and pluripotency in hESC cells grown in conditions that induce differentiation (Bhanu et al.; Desbordes et al.)
  • Inhibits tumor growth in models of prostate cancer, familial adenomatous polyposis, and brain cancer (King, Jr & Khalili; Grubbs et al.; Wechter et al.; Zemskova et al.)

Specifications

CAS 5104-49-4
Synonym Ansaid
Quantity 5 g
Molecular Formula C15H13FO2
Purity ≥99%
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.